Advertisement
Screener

Tilray Brands, Inc. (TLRY) Gross Profit

Tilray Brands, Inc. Gross Profit

Tilray Brands, Inc. (TLRY) reported Gross Profit of $260.44 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-28.

Financial Statements › Income Statement

us-gaap:GrossProfit · last filed 2026-07-28

  • Tilray Brands, Inc. gross profit for the quarter ending 2026-05-31 was $90.52M, a 33.84% increase year-over-year.
  • Tilray Brands, Inc. gross profit for the quarter ending 2026-02-28 was $54.95M, a 5.66% increase year-over-year.
  • Tilray Brands, Inc. gross profit for the quarter ending 2025-11-30 was $57.50M, a 6.08% decline year-over-year.
  • Tilray Brands, Inc. gross profit for the quarter ending 2025-08-31 was $57.47M, a 3.75% decline year-over-year.
  • Tilray Brands, Inc. gross profit for fiscal 2026 was $260.44M, a 8.26% increase from fiscal 2025.
  • Tilray Brands, Inc. gross profit for fiscal 2025 was $240.57M, a 7.71% increase from fiscal 2024.
  • Tilray Brands, Inc. gross profit for fiscal 2024 was $223.35M, a 51.98% increase from fiscal 2023.
  • Tilray Brands, Inc. gross profit for fiscal 2023 was $146.96M, a 25.80% increase from fiscal 2022.
Period endGross Profit 3 monthGross Profit 3 month as first filedGross Profit 6 monthGross Profit 6 month as first filedGross Profit 9 monthGross Profit 12 month
2026-05-31$90.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28
$145.47M
derived: sum of 2 quarters · filed 2026-07-28
$202.97M
derived: sum of 3 quarters · filed 2026-07-28
$260.44M
10-K · filed 2026-07-28
2026-02-28$54.95M
10-Q · filed 2026-04-01
$112.45M
derived: sum of 2 quarters · filed 2026-04-01
$169.92M
10-Q · filed 2026-04-01
$237.55M
derived: sum of 4 quarters · filed 2026-07-28
2025-11-30$57.50M
10-Q · filed 2026-01-08
$114.97M
10-Q · filed 2026-01-08
$182.60M
derived: sum of 3 quarters · filed 2026-07-28
$234.61M
derived: sum of 4 quarters · filed 2026-07-28
2025-08-31$57.47M
10-Q · filed 2025-10-09
$125.10M
derived: sum of 2 quarters · filed 2026-07-28
$177.11M
derived: sum of 3 quarters · filed 2026-07-28
$238.33M
derived: sum of 4 quarters · filed 2026-07-28
2025-05-31$67.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28
$119.64M
derived: sum of 2 quarters · filed 2026-07-28
$180.86M
derived: sum of 3 quarters · filed 2026-07-28
$240.57M
10-K · filed 2026-07-28
2025-02-28$52.01M
10-Q · filed 2026-04-01
$113.23M
derived: sum of 2 quarters · filed 2026-04-01
$172.94M
10-Q · filed 2026-04-01
$255.29M
derived: sum of 4 quarters · filed 2026-07-28
2024-11-30$61.22M
10-Q · filed 2026-01-08
$120.93M
10-Q · filed 2026-01-08
$203.28M
derived: sum of 3 quarters · filed 2026-07-28
$252.67M
derived: sum of 4 quarters · filed 2026-07-28
2024-08-31$59.71M
10-Q · filed 2025-10-09
$142.06M
derived: sum of 2 quarters · filed 2026-07-28
$191.45M
derived: sum of 3 quarters · filed 2026-07-28
$238.86M
derived: sum of 4 quarters · filed 2026-07-28
2024-05-31$82.35M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28
$131.75M
derived: sum of 2 quarters · filed 2026-07-28
$179.16M
derived: sum of 3 quarters · filed 2026-07-28
$223.35M
10-K · filed 2026-07-28
2024-02-29$49.40M
10-Q · filed 2025-04-08
$96.81M
derived: sum of 2 quarters · filed 2025-04-08
$141.00M
10-Q · filed 2025-04-08
$208.16M
derived: sum of 4 quarters · filed 2025-07-29
2023-11-30$47.41M
10-Q · filed 2025-01-10
$91.61M
10-Q · filed 2025-01-10
$158.77M
derived: sum of 3 quarters · filed 2025-07-29
$147.07M
derived: sum of 4 quarters · filed 2025-07-29
2023-08-31$44.20M
10-Q · filed 2024-10-10
$111.36M
derived: sum of 2 quarters · filed 2025-07-29
$99.66M
derived: sum of 3 quarters · filed 2025-07-29
$142.54M
derived: sum of 4 quarters · filed 2025-07-29
2023-05-31$67.16M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-29
$55.46M
derived: sum of 2 quarters · filed 2025-07-29
$98.35M
derived: sum of 3 quarters · filed 2025-07-29
$146.96M
10-K · filed 2025-07-29
2023-02-28-$11.70M
10-Q · filed 2024-04-09
$31.18M
derived: sum of 2 quarters · filed 2024-04-09
$79.80M
10-Q · filed 2024-04-09
$73.06M
derived: sum of 4 quarters · filed 2024-10-10
2022-11-30$42.88M
10-Q · filed 2024-01-09
$40.12M
10-Q · filed 2023-01-09
$91.50M
10-Q · filed 2024-01-09
$88.74M
10-Q · filed 2023-01-09
$84.76M
derived: sum of 3 quarters · filed 2024-10-10
$124.59M
derived: sum of 4 quarters · filed 2024-10-10
2022-08-31$48.61M
10-Q · filed 2024-10-10
$41.88M
derived: sum of 2 quarters · filed 2024-10-10
$81.71M
derived: sum of 3 quarters · filed 2024-10-10
$114.48M
derived: sum of 4 quarters · filed 2024-10-10
2022-05-31-$6.73M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30
$33.10M
derived: sum of 2 quarters · filed 2024-07-30
$65.86M
derived: sum of 3 quarters · filed 2024-07-30
$116.82M
10-K · filed 2024-07-30
2022-02-28$39.83M
10-Q · filed 2023-04-10
$72.59M
derived: sum of 2 quarters · filed 2023-04-10
$123.55M
10-Q · filed 2023-04-10
$146.05M
derived: sum of 4 quarters · filed 2023-04-10
2021-11-30$32.77M
10-Q · filed 2023-01-09
$83.72M
10-Q · filed 2023-01-09
$106.22M
derived: sum of 3 quarters · filed 2023-01-09
2021-08-31$50.95M
10-Q · filed 2022-10-07
$73.45M
derived: sum of 2 quarters · filed 2022-10-07
2021-05-31$22.50M
10-K · filed 2021-07-28
$123.18M
10-K · filed 2023-07-26
2021-03-31$13.50M
10-Q · filed 2021-05-10
2021-02-28$30.46M
10-Q · filed 2022-04-06
$100.68M
10-Q · filed 2022-04-06
2020-12-31$15.46M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19
$24.66M
10-K · filed 2021-02-19
2020-12-30$16.64M
10-K · filed 2021-02-19
2020-11-30$35.28M
10-Q · filed 2022-01-10
$70.23M
10-Q · filed 2022-01-10
2020-09-30$3.33M
10-K · filed 2021-02-19
$3.74M
10-Q · filed 2020-11-09
$9.19M
10-Q · filed 2020-11-09
2020-08-31$34.95M
10-Q · filed 2021-10-07
2020-06-30-$5.82M
10-K · filed 2021-02-19
-$5.42M
10-Q · filed 2020-08-10
$5.45M
10-Q · filed 2020-08-10
2020-05-31$27.81M
10-K · filed 2021-07-28
$96.05M
10-K · filed 2022-07-28
2020-03-31$10.87M
10-Q · filed 2021-05-10
2020-02-29$25.88M
10-K · filed 2021-07-28
2019-12-31-$57.01M
10-K · filed 2021-02-19
-$23.50M
10-K · filed 2021-02-19
2019-11-30$21.81M
10-K · filed 2021-07-28
2019-09-30$15.85M
10-K · filed 2021-02-19
$33.51M
10-Q · filed 2020-11-09
2019-08-31$20.55M
10-K · filed 2021-07-28
2019-06-30$12.27M
10-K · filed 2021-02-19
$17.66M
10-Q · filed 2020-08-10
$20.79M
derived: sum of 3 quarters · filed 2021-02-19
$23.86M
derived: sum of 4 quarters · filed 2021-02-19
2019-05-31$43.51M
10-K · filed 2021-07-28
2019-03-31$5.38M
10-K · filed 2021-02-19
$8.52M
derived: sum of 2 quarters · filed 2021-02-19
$11.59M
derived: sum of 3 quarters · filed 2021-02-19
$15.76M
derived: sum of 4 quarters · filed 2021-02-19
2018-12-31$3.13M
10-K · filed 2020-03-02
$6.20M
derived: sum of 2 quarters · filed 2020-03-02
$10.38M
derived: sum of 3 quarters · filed 2020-03-02
$14.28M
10-K · filed 2021-02-19
2018-09-30$3.07M
10-K · filed 2020-03-02
$7.25M
derived: sum of 2 quarters · filed 2020-03-02
$11.14M
10-Q · filed 2019-11-13
$14.07M
derived: sum of 4 quarters · filed 2020-03-02
2018-06-30$4.18M
10-K · filed 2020-03-02
$8.07M
10-Q · filed 2019-08-13
$11.01M
derived: sum of 3 quarters · filed 2020-03-02
$13.97M
derived: sum of 4 quarters · filed 2020-03-02
2018-03-31$3.90M
10-K · filed 2020-03-02
$6.83M
derived: sum of 2 quarters · filed 2020-03-02
$9.80M
derived: sum of 3 quarters · filed 2020-03-02
$12.51M
derived: sum of 4 quarters · filed 2020-03-02
2017-12-31$2.93M
10-K · filed 2019-03-25
$5.90M
derived: sum of 2 quarters · filed 2019-03-25
$8.61M
derived: sum of 3 quarters · filed 2019-03-25
$11.38M
10-K · filed 2020-03-02
2017-09-30$2.97M
10-K · filed 2019-03-25
$5.67M
derived: sum of 2 quarters · filed 2019-03-25
$8.42M
10-Q · filed 2018-11-14
2017-06-30$2.71M
10-K · filed 2019-03-25
$5.46M
10-Q · filed 2018-08-29
2017-03-31$2.77M
10-K · filed 2019-03-25
2016-12-31$2.67M
10-K · filed 2019-03-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
Canopy Growth Corp (CGC)$0.395B
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87